BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 26598979)

  • 21. Uterine tumors resembling ovarian sex cord tumors: an update.
    Czernobilsky B
    Int J Gynecol Pathol; 2008 Apr; 27(2):229-35. PubMed ID: 18317219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian sex cord-stromal tumours: an update in recent molecular advances.
    Lim D; Oliva E
    Pathology; 2018 Feb; 50(2):178-189. PubMed ID: 29275930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DICER1 hot-spot mutations in ovarian gynandroblastoma.
    Wang Y; Karnezis AN; Magrill J; Tessier-Cloutier B; Lum A; Senz J; Gilks CB; McCluggage WG; Huntsman DG; Kommoss F
    Histopathology; 2018 Aug; 73(2):306-313. PubMed ID: 29660837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.
    Kommoss S; Gilks CB; Penzel R; Herpel E; Mackenzie R; Huntsman D; Schirmacher P; Anglesio M; Schmidt D; Kommoss F
    Histopathology; 2014 Feb; 64(3):380-8. PubMed ID: 24192202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
    Wessman S; Fuentes BB; Severin-Karlsson J; Westbom-Fremer S; Nistér M; Kokaraki G; Petta TB; Haglund F; Carlson JW
    Int J Gynecol Pathol; 2024 Jan; 43(1):78-89. PubMed ID: 37255476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.
    Hammer PM; Wang A; Beard C; Zdravkovic S; Tenney T; Liang B; Das I; Bremer R; Wang LC; McCluggage WG; Stewart CJR; Howitt BE
    Mod Pathol; 2023 Nov; 36(11):100318. PubMed ID: 37634867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation of FOXL2 in granulosa-cell tumors of the ovary.
    Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG
    N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SF1 immunohistochemistry is useful in differentiating uterine tumours resembling sex cord-stromal tumours from potential histological mimics.
    Stewart CJ; Crook M; Tan A
    Pathology; 2016 Aug; 48(5):434-40. PubMed ID: 27311867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gynecologic Manifestations of the DICER1 Syndrome.
    Stewart CJ; Charles A; Foulkes WD
    Surg Pathol Clin; 2016 Jun; 9(2):227-41. PubMed ID: 27241106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry.
    Schultz KA; Pacheco MC; Yang J; Williams GM; Messinger Y; Hill DA; Dehner LP; Priest JR
    Gynecol Oncol; 2011 Aug; 122(2):246-50. PubMed ID: 21501861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uterine tumors resembling ovarian sex cord tumors.
    Pradhan D; Mohanty SK
    Arch Pathol Lab Med; 2013 Dec; 137(12):1832-6. PubMed ID: 24283865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network.
    Maillet D; Goulvent T; Rimokh R; Vacher-Lavenu MC; Pautier P; Alexandre J; Pujade-Laurraine E; Devouassoux-Shisheboran M; Treilleux I; Ray-Coquard I; Savina A
    Gynecol Oncol; 2014 Jan; 132(1):181-7. PubMed ID: 24157616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of molecular analysis in challenging ovarian sex cord-stromal tumours: a review of 50 cases.
    Stewart CJR; Amanuel B; De Kock L; Apellaniz-Ruiz M; Carrello A; Giardina T; Grieu-Iacopetta F; Thomas MA; Foulkes WD
    Pathology; 2020 Oct; 52(6):686-693. PubMed ID: 32782216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature.
    Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
    Tohoku J Exp Med; 2013 Dec; 231(4):243-50. PubMed ID: 24257635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors.
    Baillard P; Genestie C; Croce S; Descotes F; Rouleau E; Treilleux I; Gouy S; Morice P; Ray-Coquard I; McCluggage WG; Devouassoux-Shisheboran M
    Am J Surg Pathol; 2021 Feb; 45(2):223-229. PubMed ID: 32910017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex Cord Tumor With Annular Tubules-Like Histologic Pattern in Adult Granulosa Cell Tumor: Case Report of a Hitherto Unreported Morphologic Variant.
    Chang RJ; Reuther J; Gandhi I; Roy A; Jain S; Masand RP
    Int J Surg Pathol; 2021 Jun; 29(4):433-437. PubMed ID: 32856501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sex cord-stromal tumors of the ovary : Current aspects with a focus on granulosa cell tumors, Sertoli-Leydig cell tumors, and gynandroblastomas].
    Kommoss F; Lehr HA
    Pathologe; 2019 Feb; 40(1):61-72. PubMed ID: 30659330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.
    McCluggage WG; McKenna M; McBride HA
    Int J Gynecol Pathol; 2007 Jul; 26(3):322-7. PubMed ID: 17581419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uterine tumor resembling an ovarian sex cord tumor associated with metastasis.
    Biermann K; Heukamp LC; Büttner R; Zhou H
    Int J Gynecol Pathol; 2008 Jan; 27(1):58-60. PubMed ID: 18156976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
    Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
    Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.